Royal Bank of Canada »

Kymera Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $303k 12k 25.58
2023-09-30 $66k 4.8k 13.87
2023-06-30 $67k 2.8k 24.10
2022-12-31 $137k 5.4k 25.26
2022-09-30 $10k 460 21.74
2021-06-30 $247k 5.1k 48.48
2021-03-31 $89k 2.3k 39.16
2020-12-31 $10k 160 62.50